Chemical and Toxicological Analysis of Antiretroviral Drugs
https://doi.org/10.33380/2305-2066-2019-8-4-53-60
Abstract
Introduction. Human Immunodeficiency Virus (HIV) is one of the main socially significant infection all over the world. HIV-positive patients take medical care, including antiretroviral drugs (ARVs) pharmacotherapy. Like all drugs, ARVs have lots of side effects that should be taken when prescribing drugs as part of highly active antiretroviral therapy. There are many cases when side effects of ARVs caused patients to enter the toxicology department. Therefore, the development of new methods for the analysis of ARV in biological fluids for the timely diagnosis of treatment of poisoning of this group of drugs is relevant today.
Aim. The aim of this study is development of screening analysis of atazanavir, abacavir, nevirapine, ritonavir, lopinavir, zidovudine, darunavir and efavirenz in the urine to identify these drugs as possible toxicants for poisoning by high-performance liquid chromatography with tandem massselective detection (HPLC-MS/MS).
Materials and methods. Identification of ARV was performed by HPLC-MS/MS. Methanol precipitation method was used as a sample preparation.
Results and discussion. The optimal conditions for sample preparation, chromatographic separation, and mass-spectrometric detection were selected to determine the studied ARVs. This method was tested on urine samples from patients in the Department of Acute Poisoning and Somatopsychiatric Disorders (OOSPD) with acute ARV poisoning.
Conclusion. This screening method for analyse atazanavir, abacavir, nevirapine, ritonavir, lopinavir, zidovudine, darunavir and efavirenz in human urine has been developed by HPLC-MS/MS. The developed method can be used to identify these drugs as possible toxicants in case of poisoning. The prospect for the development of the topic is the inclusion of new molecules in the method and quantitative determination of the studied ARVs.
About the Authors
T. N. KomarovRussian Federation
20/3, Nauchny proezd, Moscow, 117246
M. V. Belova
Russian Federation
3, Bol’shaya Sukharevskaya sq., Moscow, 129090;
8/2, Trubetskaya str., Mosсow, 119991
D. D. Stolyarova
Russian Federation
8/2, Trubetskaya str., Mosсow, 119991
I. E. Shohin
Russian Federation
20/3, Nauchny proezd, Moscow, 117246
D. S. Bogdanova
Russian Federation
20/3, Nauchny proezd, Moscow, 117246
O. A. Miskiv
Russian Federation
20/3, Nauchny proezd, Moscow, 117246
Yu. V. Medvedev
Russian Federation
20/3, Nauchny proezd, Moscow, 117246;
8/2, Trubetskaya str., Mosсow, 119991
I. M. Korenskaya
Russian Federation
1, Universitetskaya sq., Voronezh, 394018
References
1. Ryndich A.A., Sukhova A.G., Suladze A.G., Tverdokhlebova T.I., Vorontsov D.V. HIV epidemic trends and development factors in southern Russia. HIV Infection and Immunosuppressive Disorders. 2019; 11(2): 48-57. DOI: 10.22328/2077-9828-2019-11-2-48-57 (in Russ.).
2. Rotger M., Colombo S., Furrer H. et al. Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients. Pharmacogenet Genomics 2005; 15: 1–5.
3. Sapozhnikov V.G., Konyakhina A.P. The consequences of acute exogenous poisoning with the drug Retrovir (clinical observation). Bulletin of new medical technologies. 2016; 23(4): 188-196 (in Russ.).
4. PubChem. Methanol. Available at:https://pubchem.ncbi.nlm.nih.gov/compound/Methanol#section=Octanol-Water-Partition-Coefficient.
5. DrugBank. Available at: https://www.drugbank.ca/drugs/DB00495.
6. DrugBank. Available at: https://www.drugbank.ca/drugs/DB01601.
Review
For citations:
Komarov T.N., Belova M.V., Stolyarova D.D., Shohin I.E., Bogdanova D.S., Miskiv O.A., Medvedev Yu.V., Korenskaya I.M. Chemical and Toxicological Analysis of Antiretroviral Drugs. Drug development & registration. 2019;8(4):53-60. (In Russ.) https://doi.org/10.33380/2305-2066-2019-8-4-53-60